Both firms were heavily focused on pharma and healthcare marketing during the previous year.
Stock.adobe.com
Omnicom announced that it will acquire Interpublic in a stock-for-stock transaction.1 According to Omnicom, this will give the marketing and sales firm the deepest bench of talent in the marketing field.
In 2024, pharma and healthcare marketing was a key area for both firms, meaning that this acquisition will likely have a significant impact on the pharma industry.
Interpublic shareholders will receive 0.344 shares in Omnicom for each share of the former company’s stock that they own. As a result, Omnicom shareholders will just over 60% of the new company.
In a press release, Omnicom chairman and CEO John Wren said, “This strategic acquisition creates significant value for both sets of shareholders by combining world-class, highly complementary data and technology platforms enabling new offerings to better serve our clients and drive growth. Through this combination, we are poised to accelerate innovation and harness the significant opportunities created by new technologies in this era of exponential change. Now is the perfect time to bring together our technologies, capabilities, talent, and geographic footprints to bring clients superior, data-driven outcomes. We are excited to welcome Philippe and the entire Interpublic team to the Omnicom family.”
In the same press release, Interpublic CEO Philippe Krakowsky added, “This combination represents a tremendous strategic opportunity for our stakeholders, amplifying our investments in platform capabilities and talent as part of a more expansive network. Our two companies have highly complementary offerings, geographic presence and cultures. We also share a foundational belief in the power of ideas, enabled by technology and data. By joining Omnicom, we are creating a uniquely comprehensive portfolio of services that will make us the most powerful marketing and sales partner in a world that’s changing at speed. We look forward to working with John and the entire Omnicom team.”
In November of this year, Omnicom Group announced that its agency OMD Wordwide had been named the best performing global media network overall by RECMA in its annual Network Diagnostics report.2
In a press release issued at the time, OM Worldwide CEO George Manas said, “We’ve entered a new era of agency/client relationships in which the bar has been raised from transactional to transformational–and by that, I mean we must be partners in accelerating our clients’ business ambitions. As these results demonstrate, OMD–powered by the Omni open operating system and enabled by OMG’s Agency as a Platform model that connects media, content, and commerce–has the talent, tools, and technology to cross this higher bar, collaborating with our clients to co-create solutions that unlock growth and secure lasting competitive advantage.”
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.